Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Short term Debt (2024 - 2025)

Historic Short term Debt for Kezar Life Sciences (KZR) over the last 2 years, with Q3 2025 value amounting to $5.3 million.

  • Kezar Life Sciences' Short term Debt rose 3490.93% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 3490.93%. This contributed to the annual value of $5.2 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Kezar Life Sciences' Short term Debt is $5.3 million, which was up 3490.93% from $5.3 million recorded in Q2 2025.
  • Kezar Life Sciences' 5-year Short term Debt high stood at $5.3 million for Q2 2025, and its period low was $1.3 million during Q1 2024.